Ysios news
04.12.19
Anaconda biomed secures €20 million round of funding
16.07.19
AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury
portfolio news
27.04.20
Galecto Appoints Jonathan Freve as Chief Financial Officer
31.03.20
AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI
